| Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo F Chen, G Wang, JI Griffin, B Brenneman, NK Banda, VM Holers, ... Nature nanotechnology 12 (4), 387-393, 2017 | 491 | 2017 |
| Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles VP Vu, GB Gifford, F Chen, H Benasutti, G Wang, EV Groman, ... Nature nanotechnology 14 (3), 260-268, 2019 | 227 | 2019 |
| Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery MR Papasani, G Wang, RA Hill Nanomedicine: Nanotechnology, Biology and Medicine 8 (6), 804-814, 2012 | 167 | 2012 |
| Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonization and leukocyte uptake S Inturi, G Wang, F Chen, NK Banda, VM Holers, LP Wu, SM Moghimi, ... ACS nano 9 (11), 10758-10768, 2015 | 100 | 2015 |
| Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum NK Banda, G Mehta, Y Chao, G Wang, S Inturi, L Fossati-Jimack, M Botto, ... Particle and fibre toxicology 11, 1-10, 2014 | 94 | 2014 |
| Nanoscale structure–activity relationships, mode of action, and biocompatibility of gold nanoparticle antibiotics J Bresee, CM Bond, RJ Worthington, CA Smith, JC Gifford, CA Simpson, ... Journal of the American Chemical Society 136 (14), 5295-5300, 2014 | 83 | 2014 |
| High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties G Wang, S Inturi, NJ Serkova, S Merkulov, K McCrae, SE Russek, ... ACS nano 8 (12), 12437-12449, 2014 | 66 | 2014 |
| Activation of human complement system by dextran-coated iron oxide nanoparticles is not affected by dextran/Fe ratio, hydroxyl modifications, and crosslinking G Wang, F Chen, NK Banda, VM Holers, LP Wu, SM Moghimi, D Simberg Frontiers in immunology 7, 418, 2016 | 58 | 2016 |
| KDEL peptide gold nanoconstructs: promising nanoplatforms for drug delivery G Wang, AS Norton, D Pokharel, Y Song, RA Hill Nanomedicine: Nanotechnology, Biology and Medicine 9 (3), 366-374, 2013 | 53 | 2013 |
| In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized … G Wang, JI Griffin, S Inturi, B Brenneman, NK Banda, VM Holers, ... Frontiers in immunology 8, 151, 2017 | 49 | 2017 |
| Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer DC Julien, S Behnke, G Wang, GK Murdoch, RA Hill MAbs 3 (5), 467-478, 2011 | 46 | 2011 |
| Variability of complement response toward preclinical and clinical nanocarriers in the general population H Benasutti, G Wang, VP Vu, R Scheinman, E Groman, L Saba, ... Bioconjugate chemistry 28 (11), 2747-2755, 2017 | 45 | 2017 |
| Gold-peptide nanoconjugate cellular uptake is modulated by serum proteins G Wang, MR Papasani, P Cheguru, PJ Hrdlicka, RA Hill Nanomedicine: Nanotechnology, Biology and Medicine 8 (6), 822-832, 2012 | 37 | 2012 |
| Feraheme (ferumoxytol) is recognized by proinflammatory and anti-inflammatory macrophages via scavenger receptor type AI/II G Wang, NJ Serkova, EV Groman, RI Scheinman, D Simberg Molecular pharmaceutics 16 (10), 4274-4281, 2019 | 29 | 2019 |
| Revealing dynamics of accumulation of systemically injected liposomes in the skin by intravital microscopy JI Griffin, G Wang, WJ Smith, VP Vu, R Scheinman, D Stitch, R Moldovan, ... ACS nano 11 (11), 11584-11593, 2017 | 27 | 2017 |
| Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55 G Gifford, VP Vu, NK Banda, VM Holers, G Wang, EV Groman, D Backos, ... Journal of controlled release 302, 181-189, 2019 | 25 | 2019 |
| Complement opsonization of nanoparticles: Differences between humans and preclinical species Y Li, G Wang, L Griffin, NK Banda, LM Saba, EV Groman, R Scheinman, ... Journal of Controlled Release 338, 548-556, 2021 | 23 | 2021 |
| Thiol-modified gold nanoparticles for the inhibition of Mycobacterium smegmatis JC Gifford, J Bresee, CJ Carter, G Wang, RJ Melander, C Melander, ... Chemical communications 50 (100), 15860-15863, 2014 | 23 | 2014 |
| Targeted intracellular delivery of trastuzumab using designer phage lambda nanoparticles alters cellular programs in human breast cancer cells A Catala, M Dzieciatkowska, G Wang, A Gutierrez-Hartmann, D Simberg, ... ACS nano 15 (7), 11789-11805, 2021 | 22 | 2021 |
| Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles G Wang, H Benasutti, JF Jones, G Shi, M Benchimol, S Pingle, S Kesari, ... Colloids and Surfaces B: Biointerfaces 161, 200-209, 2018 | 18 | 2018 |
SM MoghimiProfessor of Pharmaceutics and Nanomedicine; School of Pharmacy and Institute of Cellular MedicineGeverifieerd e-mailadres voor ncl.ac.uk
